Search

everythinglearnresearchcommunity

for

Search:↓

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Nonmelanoma skin cancers have higher levels of certain osteopontin variants than normal skin.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The research suggests that Tourette syndrome is linked to both brain signaling and immune system pathways.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Septin4 helps kill colon cancer cells by working with the protein BAX.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Nanoparticles improve cancer treatment by reducing side effects and targeting cancer cells better.

Imaging intestinal stem cells might help detect early signs of colorectal cancer.

The paper concludes that breast cancer treatment involves complex interactions between medical symptoms, patient experiences, and commercial influences, requiring a holistic approach.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Nanozymes show promise for effective and safe cancer treatment.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Surface-modified nanoparticles mainly use non-follicular pathways to enhance skin permeation of ibuprofen and could improve treatment for inflammatory skin diseases.

Nobiletin-loaded vesicles effectively treat skin cancer by restoring normal miRNA and antioxidant levels.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Ginsenoside Rb1 from Panax ginseng helps mink hair grow by activating certain cell signals.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

c-Kit is important for heart regeneration and cancer development.